Literature DB >> 16928759

The unique C termini of orthopoxvirus gamma interferon binding proteins are essential for ligand binding.

Anthony A Nuara1, Hongdong Bai, Nanhai Chen, R Mark L Buller, Mark R Walter.   

Abstract

The orthopoxviruses ectromelia virus (ECTV) and vaccinia virus (VACV) express secreted gamma interferon binding proteins (IFN-gammaBPs) with homology to the ligand binding domains of the host's IFN-gamma receptor (IFN-gammaR1). Homology between these proteins is limited to the extracellular portions of the IFN-gammaR1 and the first approximately 200 amino acids of the IFN-gammaBPs. The remaining 60 amino acids at the C termini of the IFN-gammaBPs contain a single cysteine residue shown to be important in covalent dimerization of the secreted proteins. The function of the remaining C-terminal domain (CTD) has remained elusive, yet this region is conserved within all orthopoxvirus IFN-gammaBPs. Using a series of C-terminal deletion constructs, we have determined that the CTD is essential for IFN-gamma binding despite having no predicted homology to the IFN-gammaR1. Truncation of the ECTV IFN-gammaBP by more than two amino acid residues results in a complete loss of binding activity for both murine IFN-gamma and human IFN-gamma (hIFN-gamma), as measured by surface plasmon resonance (SPR) and bioassay. Equivalent truncation of the VACV IFN-gammaBP resulted in comparable loss of hIFN-gamma binding activity by SPR. Full-length IFN-gammaBPs were observed to form higher-ordered structures larger than the previously reported dimers. Mutants that were unable to bind IFN-gamma with high affinity in SPR experiments failed to assemble into these higher-ordered structures and migrated as dimers. We conclude that the unique CTD of orthopoxvirus IFN-gammaBPs is important for the assembly of covalent homodimers as well as the assembly of higher-ordered structures essential for IFN-gamma binding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928759      PMCID: PMC1641743          DOI: 10.1128/JVI.01015-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation.

Authors:  D Beckett; E Kovaleva; P J Schatz
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

Review 2.  Vaccinia virus immune evasion.

Authors:  G L Smith; J A Symons; A Khanna; A Vanderplasschen; A Alcamí
Journal:  Immunol Rev       Date:  1997-10       Impact factor: 12.988

3.  The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines.

Authors:  A S Lalani; K Graham; K Mossman; K Rajarathnam; I Clark-Lewis; D Kelvin; G McFadden
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  The vaccinia virus soluble interferon-gamma receptor is a homodimer.

Authors:  Antonio Alcamí; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2002-03       Impact factor: 3.891

5.  Soluble interferon-gamma receptors encoded by poxviruses.

Authors:  A Alcamí; G L Smith
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1996-09       Impact factor: 2.268

6.  Expression of secreted cytokine and chemokine inhibitors by ectromelia virus.

Authors:  V P Smith; A Alcami
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  Analysis of host response modifier ORFs of ectromelia virus, the causative agent of mousepox.

Authors:  N Chen; R M Buller; E M Wall; C Upton
Journal:  Virus Res       Date:  2000-02       Impact factor: 3.303

8.  Complete coding sequences of the rabbitpox virus genome.

Authors:  G Li; N Chen; R L Roper; Z Feng; A Hunter; M Danila; E J Lefkowitz; R M L Buller; C Upton
Journal:  J Gen Virol       Date:  2005-11       Impact factor: 3.891

9.  A third distinct tumor necrosis factor receptor of orthopoxviruses.

Authors:  V N Loparev; J M Parsons; J C Knight; J F Panus; C A Ray; R M Buller; D J Pickup; J J Esposito
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

10.  A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus.

Authors:  Alí Alejo; M Begoña Ruiz-Argüello; Yin Ho; Vincent P Smith; Margarida Saraiva; Antonio Alcami
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 12.779

View more
  7 in total

1.  Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection.

Authors:  Isaac G Sakala; Geeta Chaudhri; R Mark Buller; Anthony A Nuara; Hongdong Bai; Nanhai Chen; Gunasegaran Karupiah
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 2.  Poxvirus proteomics and virus-host protein interactions.

Authors:  Kim Van Vliet; Mohamed R Mohamed; Leiliang Zhang; Nancy Yaneth Villa; Steven J Werden; Jia Liu; Grant McFadden
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

Review 3.  Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures.

Authors:  Jan Felix; Savvas N Savvides
Journal:  Nat Rev Immunol       Date:  2016-12-28       Impact factor: 53.106

Review 4.  Subversion of cytokine networks by virally encoded decoy receptors.

Authors:  Megan L Epperson; Chung A Lee; Daved H Fremont
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

5.  Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gamma-binding protein.

Authors:  Anthony A Nuara; Leigh J Walter; Naomi J Logsdon; Sung Il Yoon; Brandi C Jones; Jill M Schriewer; R Mark Buller; Mark R Walter
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-05       Impact factor: 11.205

6.  A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.

Authors:  Jennifer Stabenow; R Mark Buller; Jill Schriewer; Cheri West; John E Sagartz; Scott Parker
Journal:  J Virol       Date:  2010-02-03       Impact factor: 6.549

7.  Structural basis of chemokine sequestration by a tick chemokine binding protein: the crystal structure of the complex between Evasin-1 and CCL3.

Authors:  João M Dias; Christophe Losberger; Maud Déruaz; Christine A Power; Amanda E I Proudfoot; Jeffrey P Shaw
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.